Revvity Inc vs Wells Fargo & Co — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Wells Fargo & Co trades at $87.8 (market cap $261.45B). The key difference: Wells Fargo & Co is far larger — about 22× Revvity Inc's market cap, and Wells Fargo & Co pays the higher dividend (2.09%). Which is the better fit depends on your goals.
| RVTY | WFC | |
|---|---|---|
Market Cap | $11.87B | $261.45B |
Sector | Technology | Financials |
52-Week High | $117.75 | $96.40 |
52-Week Low | $82.26 | $73.42 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | 2.09% |
Trailing returns across standard periods
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →